HDAC9 and cancer: Several studies proved that HDAC inhibition results in inactivation of the mechanistic target of rapamycin (mTOR), thus promoting autophagy [44,45], while acetylation is described as a mechanistic switch in favor of anti-cancer processes in HCC and CCA in vitro [46,47,48].